2 withdrawn, 1 completed. 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Withdrawn 2 |
| Phase 3 | 1 | Completed 1 |
Follow nanocis: new trials by email Literature Review of nanocis trials Research Report on nanocis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery Indocyanine green, Technetium99, Optonuclear probe - Breast Carcinoma, Head and Neck Cancer | Phase 3 | Completed | Institut de Cancérologie de Lorraine | 744 | 2017-11-29 | 2026-09-01 |
| Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin Intraperitoneal cisplatin with nanocis - Ovarian Cancer | Not applicable | Withdrawn | Centre Jean Perrin | 2016-03-01 | 2016-10-11 | |
| Diagnosis of Microaspiration in Intubated Critically Ill Patients: Pepsin vs 99m Technetium 99mTc-Rhenium Sulfide Nanocolloid - Critical Illness | Not applicable | Withdrawn | University Hospital, Lille | 2015-09-01 | 2015-12-04 |
Ovarian Neoplasms (2) · Anus Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Squamous Cell (1) · Critical Illness (1) · Endometrial Neoplasms (1) · Head and Neck Neoplasms (1) · Melanoma (1) · Neoplasms (1) · Rectal Neoplasms (1) · Uterine Cervical Neoplasms (1) · Vulvar Neoplasms (1)
Centre Jean Perrin (1) · Institut de Cancérologie de Lorraine (1) · University Hospital, Lille (1)
France (3)
Christophe Pomel, MD, PhD (1) · Saad Nseir, MD, PhD (1)